Fast, Fair, Cancer Care is a global initiative calling for a clear shift in how cancer diagnostics is funded and delivered.
The call to action is clear:
Improve access to advanced cancer testing by making liquid biopsy publicly reimbursed to help guide care.
We want to see liquid biopsy tests brought into every community and reimbursed if a doctor determines a patient can benefit from this minimally invasive test.
That’s because faster diagnosis, fairer access, and smarter use of resources belong in every conversation about cancer care.
Join Fast, Fair, Cancer Care by posting about it anytime this April.
Stand with me — and with patients everywhere.
I support Fast, Fair, Cancer Care. Join me.
